Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Meningioma 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Chordoma 1Carcinoma, Non-Small-Cell Lung 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 2Specimen Handling 2Early Intervention, Educational 2pertuzumab 1X-Ray Therapy 1Watchful Waiting 1Trastuzumab 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Protons 1Proton Therapy 1Practice Guidelines as Topic 1Paclitaxel 1Observation 1Motivational Interviewing 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1High-Energy Shock Waves 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Anatomic Stage I Breast Cancer AJCC v8 × Protons × Clear all
NCT04443413 2026-01-16

Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients

Mayo Clinic

Phase 3 Active not recruiting
146 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡